Study on Prognosis of Patients With Implantable Cardioverter Defibrillator (ICD)
Not Applicable
- Conditions
- Patients with ICD
- Registration Number
- JPRN-UMIN000018225
- Lead Sponsor
- Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were judged inappropriate by the principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all-cause death heart failure death sudden cardiac death hospitalization for worsening of heart failure appropriate ICD discharge for ventricular tachyarrhythmias
- Secondary Outcome Measures
Name Time Method Incidence of ventricular tachycardia and ventricular fibrillation Appropriate / inappropriate therapy of ICD Change of QOL using SF-36
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence ICD efficacy in patients with arrhythmias and heart failure?
How does ICD therapy compare to standard-of-care treatments for ventricular tachycardia and fibrillation?
Which biomarkers predict optimal outcomes for ICD implantation in ischemic versus non-ischemic cardiomyopathy?
What are the most common adverse events associated with ICD devices and how are they managed in clinical practice?
Are there emerging therapies or combination strategies that complement ICD function in preventing sudden cardiac death?